###begin article-title 0
Retinoblastoma Loss Modulates DNA Damage Response Favoring Tumor Progression
###end article-title 0
###begin p 1
Conceived and designed the experiments: MS PI JAC. Performed the experiments: MS PI TG CA. Analyzed the data: MS PI TG MF JAC. Contributed reagents/materials/analysis tools: FD JF. Wrote the paper: MS PI JAC.
###end p 1
###begin p 2
###xml 801 803 801 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1010 1013 1010 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1025 1027 1025 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1138 1140 1138 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 538 543 <span type="species:ncbi:9606">human</span>
Senescence is one of the main barriers against tumor progression. Oncogenic signals in primary cells result in oncogene-induced senescence (OIS), crucial for protection against cancer development. It has been described in premalignant lesions that OIS requires DNA damage response (DDR) activation, safeguard of the integrity of the genome. Here we demonstrate how the cellular mechanisms involved in oncogenic transformation in a model of glioma uncouple OIS and DDR. We use this tumor type as a paradigm of oncogenic transformation. In human gliomas most of the genetic alterations that have been previously identified result in abnormal activation of cell growth signaling pathways and deregulation of cell cycle, features recapitulated in our model by oncogenic Ras expression and retinoblastoma (Rb) inactivation respectively. In this scenario, the absence of pRb confers a proliferative advantage and activates DDR to a greater extent in a DNA lesion-independent fashion than cells that express only HRasV12. Moreover, Rb loss inactivates the stress kinase DDR-associated p38MAPK by specific Wip1-dependent dephosphorylation. Thus, Rb loss acts as a switch mediating the transition between premalignant lesions and cancer through DDR modulation. These findings may have important implications for the understanding the biology of gliomas and anticipate a new target, Wip1 phosphatase, for novel therapeutic strategies.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 687 692 <span type="species:ncbi:9606">human</span>
Cell proliferation is dependent on the appropriate transmission of growth signals from the cell membrane to the nucleus. Ras family proteins function as a membrane-associated biologic switch that relays signals from ligand-stimulated receptors to cytoplasmatic downstream effectors proteins like phosphoinositide 3-kinase (PI3K) and Raf-MEK1/2. These protein-kinases are responsible of phosphorylation of transcription factors, which in last instance contribute to proliferation, differentiation and cell survival. The importance of the Ras/Raf/MEK/ERK pathway in growth control is further supported by the fact that hyperactivation of this pathway is usually found associated with many human tumors such as gliomas.
###end p 4
###begin p 5
###xml 144 147 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Kleihues1">[1]</xref>
###xml 623 626 623 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Guha1">[2]</xref>
###xml 627 630 627 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Rajasekhar1">[4]</xref>
###xml 703 706 703 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Hu1">[5]</xref>
###xml 816 819 816 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Ding1">[6]</xref>
###xml 820 823 820 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Rich1">[8]</xref>
###xml 724 729 <span type="species:ncbi:10090">mouse</span>
Gliomas are the most common primary tumors in the brain and are divided into four clinical grades on the basis of their histology and prognosis [1]. Several gene expression alterations and chromosomal abnormalities are commonly found in gliomas, and in some cases these mutations correlate with clinical grade. One common alteration in gliomas of all grades is the overproduction of growth factors such as FGF2, EGFR and PDGF19, and their receptors. Interestingly, although mutations in Ras are not found in gliomas, overexpression and/or gain-of-function mutations in several growth factor receptors increase Ras activity [2]-[4], activating downstream effectors like Raf/MEK/ERK and PI3K/AKT pathways [5]. Indeed, several mouse models of glioma have causally implicated activated HRas and KRas in glioma formation [6]-[8].
###end p 5
###begin p 6
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDK4</italic>
###xml 348 357 348 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a&#8211;ARF</italic>
###xml 361 363 361 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 421 430 421 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a&#8211;ARF</italic>
###xml 437 440 437 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Jen1">[9]</xref>
###xml 442 446 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Schmidt1">[10]</xref>
###xml 480 485 480 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 493 496 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 537 541 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Quelle1">[11]</xref>
###xml 621 625 621 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDK4</italic>
###xml 644 646 644 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 652 656 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-He1">[12]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Ichimura1">[14]</xref>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Rathore1">[15]</xref>
###xml 389 394 <span type="species:ncbi:9606">human</span>
Deregulation of signal transduction pathways mutations is found both in low- and high-grade gliomas, whereas other mutations are predominantly found in one or another group of gliomas. Thus, nearly all WHO grade III and IV (GBM) show a disruption of cell cycle due to alterations in one out of three genetic loci governing G1 arrest such as: CDK4, INK4a-ARF or Rb. Over half of high-grade human gliomas lack a functional INK4a-ARF locus [9], [10] and hence can produce neither p16INK4a nor p19ARF, the two proteins encoded by this locus [11]. Most of the remaining gliomas either demonstrate a great amplification of the CDK4 locus or lack the Rb gene [12]-[14] conjointly, in some cases, with p53 alterations [15].
###end p 6
###begin p 7
###xml 79 80 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Brookes1">[16]</xref>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Serrano1">[17]</xref>
###xml 202 207 202 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 345 348 345 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 356 361 356 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Collado1">[18]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-DiMicco1">[21]</xref>
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 381 387 <span type="species:ncbi:10090">murine</span>
###xml 429 434 <span type="species:ncbi:9606">human</span>
Curiously, in human and rodent cells, oncogenic signals result in a permanent G1 arrest known as OIS [16], [17]. Although diverse stimuli can induce a senescence response, they appear to converge on p16INK4a/pRb and/or p19ARF/p53 pathways that establish and maintain the senescence growth arrest. In fact, increased expression levels of p53, p19ARF and p16INK4a have been found in murine cells undergoing OIS, as well as in some human premalignant neoplastic lesions [18]-[21].
###end p 7
###begin p 8
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Bartkova1">[19]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Gorgoulis1">[20]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Bartkova2">[22]</xref>
Several oncogenes like Ras induce DNA replication stress, which leads to activation of the DNA damage response (DDR). This response includes phosphorylation of kinases such as ATM and Chk2, histone H2AX and p53 [19], [20], [22], which ultimately force the cell to undergo oncogene-induced senescence (OIS). Like apoptosis, OIS is a tumor-suppressing defense mechanism that must be compromised for tumorigenesis to occur.
###end p 8
###begin p 9
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Wang1">[23]</xref>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Bulavin1">[24]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Dolado1">[25]</xref>
In the same way, recent studies have revealed a major role of the p38MAPK pathway in OIS caused by oncogenic Ras [23], [24]. Although, part of the tumor-suppressive function of p38MAPK is attributed to its ability to mediate apoptosis as a result of ROS accumulation induced by activated oncogenes [25].
###end p 9
###begin p 10
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Holland1">[26]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Uhrbom1">[28]</xref>
###xml 511 513 511 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 840 844 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Powers1">[29]</xref>
###xml 992 994 992 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1220 1224 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Hershko1">[30]</xref>
Here, we have developed a new model for gliomagenesis in hopes of understanding these patterns and discerning the contributions made to tumor formation. Similar approaches have been used before by other groups to recreate the behavior of glioma cells introducing in astrocytes some of the genetic lesions mentioned above [26]-[28]. We demonstrate that astrocytes are resistant to Ras-induced senescence in presence of high levels of ROS and DNA damage despite DDR activation. Moreover, in this context, loss of Rb locus favors the progression of low-grade gliomas to higher-grade tumors by conferring a double selective advantage to the tumor. First, deregulation of the pRb-E2F1 pathway is able to stimulate DDR activation through activation of ATM to phosphorylate p53 without increasing DNA double-strand breaks (DSBs) or ROS production [29]. This preferential activation of the DNA damage response increases DNA repair capacity that is essential for tumor cell survival. Finally, loss of Rb locus negatively regulates p38MAPK phosphorylation. Down-regulation of the p38MAPK signaling pathway is achieved through E2F-induced up-regulation of Wip1, a specific phosphatase that dephosphorylates and inactivates p38MAPK [30], also favoring the progression to astrocyte transformation.
###end p 10
###begin title 11
Results
###end title 11
###begin p 12
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Holland3">[31]</xref>
###xml 184 187 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 195 197 195 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 218 220 218 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 317 319 317 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 404 407 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 489 491 489 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Marino1">[32]</xref>
###xml 221 227 <span type="species:ncbi:10090">murine</span>
###xml 327 332 <span type="species:ncbi:10090">mouse</span>
Considering that upregulation of growth factor signaling pathways and the loss of cell cycle regulators are common features in glioblastoma multiforme [31], we address the role of HRasV12 and/or Rb loss in conditional Rb murine astrocytes to explain the tumor initiation and maintenance. To this purpose, conditional Rb mutant mouse astrocytes were infected by retrovirus encoding mutant Ras allele (HRasV12) and the recombinase Cre that targets the loxP sequences flanking exon 19 of the Rb gene [32]. Thus, we managed to mimic the characteristic upregulation of EGFR and FGFR signaling pathways by introducing a constitutively activated isoform of Ras, and the cell cycle deregulation by genetically inactivating the pocket protein Rb.
###end p 12
###begin p 13
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Serrano1">[17]</xref>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Peeper1">[33]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Lee1">[34]</xref>
###xml 413 416 413 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
However, previous studies have reported that primary MEFs enter senescence upon oncogenic stress induced by ectopic expression of the oncogenic HRasV12[17], [33]. Also, it has been reported that the absence of pRb enables Ras activation modulating differentiation in MEFs [34]. Accordingly, we carried out several infection assays on MEFs where we observed that all experimental groups enter senescence after HRasV12 expression (data not shown), as others reported.
###end p 13
###begin p 14
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 112 114 112 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 272 274 272 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 274 277 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 305 307 305 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 307 316 307 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 403 406 403 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 419 421 419 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 421 430 421 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 434 437 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 545 547 545 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 547 556 547 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 560 563 560 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 658 667 658 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g001">Figure 1A</xref>
###xml 789 806 789 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g001">Figures 1B and 1C</xref>
Unexpectedly, we observed that the astrocytes infected with PIG-Cre/pBABE-HRasV12 retroviral vector (hereafter cRb-/-/RasV12) showed after one week an increased proliferation rate when compared with the remaining groups. Astrocytes infected with PIG-Cre/pBABE (hereafter cRb-/-) and PIG/pBABE (hereafter cRbloxP/loxP) were used as control groups. To our surprise, astrocytes infected with PIG/pBABE-HRasV12 (hereafter cRbloxP/loxP/RasV12) also displayed a dramatic increment when compared with the control group, although at a less extent than cRbloxP/loxP/RasV12 astrocytes. Proliferative differences between astrocytic populations can be easily spotted in Figure 1A. To further support these data, we carried out a BrdU incorporation assay on all of the experimental groups, as shown in Figures 1B and 1C, that confirmed our initial observation.
###end p 14
###begin title 15
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse astrocytes are defective for HRasv12-induced cell cycle arrest.
###end title 15
###begin p 16
###xml 43 45 43 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 45 54 45 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 170 173 170 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 647 656 645 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 645 656 643 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>loxP/loxP</sup></italic>
###xml 664 667 662 665 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 662 667 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>&#8722;/&#8722;</sup></italic>
a, Growth curve analysis of early-passage cRbloxP/loxP conditional astrocytes co-infected with PIG/pBABE (vector), PIG/pBABE-HRasV12, PIG-Cre/pBABE and PIG-Cre/pBABE-HRasV12 retroviral vectors. After infection, cells were plated in triplicate and the cells were fixed on the indicated days for subsequent staining with crystal violet. Each time point represents the mean+/-s.d. of total cumulative cell number from at least three independent experiments. b, Measurement of the proliferation of astrocytes by BrdU incorporation assay (panel c). c, Cells were labeled with BrdU for 5 h on day 5 after puromycin selection. d, Senescence assays in cRbloxP/loxP and cRb-/-. The y-axis represents the percentage of SA-beta-galactosidase-positive cells (mean and s.d.) from at least three independent experiments. e, A representative result of three independent experiments is shown. Photographs are at the same magnification.
###end p 16
###begin p 17
###xml 57 59 57 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 59 68 59 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 81 83 81 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 145 154 142 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g001">Figure 1E</xref>
###xml 424 426 421 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 521 538 518 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g001">Figures 1D and 1E</xref>
###xml 641 645 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Sathyan1">[35]</xref>
These data is compatible with the observation that both cRbloxP/loxP/RasV12 and cRb-/-/RasV12 groups did not show SA-beta-Gal positive staining (Figure 1E), either in the presence or absence of pRb. Thus, our findings suggest that oncogenic Ras alone, regardless of pRb status, is sufficient to increase proliferation in astrocytes and at the same time, circumvent the oncogene-induced senescence seen in MEFs. Furthermore, Rb loss cooperates with oncogenic Ras enhancing the growth rate but without inducing senescence (Figures 1D and 1E) or apoptosis in astrocytes (data not shown), as others previously reported in other cellular systems [35].
###end p 17
###begin p 18
###xml 337 346 337 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g002">Figure 2A</xref>
###xml 393 395 393 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 772 781 772 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g002">Figure 2B</xref>
###xml 793 796 793 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 837 839 837 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 839 848 839 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 852 855 852 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 861 863 861 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 863 866 863 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 870 873 870 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
Unlike normal primary astrocytes, flattened and non-refractile cells, Ras-expressing astrocytes showed noticeable morphological changes and loss of contact inhibition, and although flat cells were also present, the population was heterogeneous and large displaying at the same time a refractile cytoplasm with thin and long projections (Figure 2A). It is also revealing the fact that although Rb-deficient astrocytes displayed a marked proliferative increase its morphology did not appear significantly changed. On the contrary, Ras-expressing astrocytes seemed to undergo dramatic morphological alterations suggesting a transformed phenotype. We then wondered if these astrocytes would also exhibit foci growth, which is a characteristic feature of transformed cells. As Figure 2B shows, HRasV12 seems to induce foci growth as seen in cRbloxP/loxP/RasV12 and cRb-/-/RasV12 cells, whereas the remaining groups do not show significant foci formation.
###end p 18
###begin title 19
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 26 28 26 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
HRasV12 in the absence of Rb induces malignant transformation both in vitro and in vivo.
###end title 19
###begin p 20
###xml 347 349 347 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 349 352 349 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 356 359 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 439 441 439 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 441 450 441 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 454 457 454 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 463 465 463 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 465 468 465 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 472 475 472 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 585 587 585 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 587 596 587 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 600 603 600 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 832 835 832 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 829 835 829 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cRb<sup>&#8722;/&#8722;</sup></italic>
###xml 839 842 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
a, Ability to form foci, representative pictures of wells stained with crystal violet (day 7). b, Representative pictures of wells stained on the indicated days of culture showing the morphological change observed in each group are also shown. c, Tumor-free survival curve (Kaplan-Meier plot) for tumor formation in SCID mice. Tumor was found in cRb-/-/RasV12 cohort (P<0.0001) d, Photographs of SCID mice after subcutaneous injection of cRbloxP/loxP/RasV12 and cRb-/-/RasV12 astrocytes at eleven and two weeks respectively. Actual sizes of tumors after biopsy. e. Low-grade gliomas (cRbloxP/loxP/RasV12; H&E, upper left) showed a rather monomorphic appearance, with polygonal or rounded cell shape and smaller rounded nuclei without prominent nucleoli. Note the absence of mitosis and necrosis. In contrast, high-grade gliomas (cRb-/-/RasV12; H&E, lower left) displayed cellular pleomorphism, with large, fusiform and irregular nuclei that frequently exhibit mitotic figures (upper left corner) and necrotic foci (lower right corner). Co-expression of EGFP permits the visualization of the previously modified astrocytes.
###end p 20
###begin p 21
###xml 154 156 154 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 156 165 156 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 272 274 272 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 274 277 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 401 403 401 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 403 412 403 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 428 430 428 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 430 433 430 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 456 473 456 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g002">Figures 2C and 2D</xref>
###xml 512 515 512 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 520 522 520 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 584 587 584 587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
To further support the hypothesis concerning the transformed status of these cells, we injected subcutaneously all the experimental groups in SCID mice. cRbloxP/loxP/RasV12 astrocytes formed detectable tumors (N = 2/13; p = NS) within 8-15 weeks whereas tumors formed by cRb-/-/RasV12 (N = 13/13; p<0.0001) appeared in-between the first and second week. No tumors were observed in mice injected with cRbloxP/loxP (N = 0/11) or cRb-/- (N = 0/7) astrocytes (Figures 2C and 2D). Together, our data suggest that HRasV12 and Rb loss promote the transformation of those cells. However, HRasV12 alone is also able to induce tumor growth in a minor extent and with a long latency, suggesting that in this case a second oncogenic event is needed to trigger tumorigenesis.
###end p 21
###begin p 22
###xml 61 63 61 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 63 66 63 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 121 130 121 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g002">Figure 2E</xref>
###xml 348 350 348 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 350 359 350 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 479 488 479 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g002">Figure 2E</xref>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Serrano1">[17]</xref>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-DiMicco1">[21]</xref>
###xml 556 560 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Peeper1">[33]</xref>
###xml 732 735 732 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 823 830 823 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 854 856 854 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 912 915 912 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 939 960 939 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g001">Figures 1A, 1B and 1C</xref>
###xml 1014 1031 1014 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g002">Figures 2C and 2D</xref>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 408 413 <span type="species:ncbi:9606">human</span>
Histopathological examinations of the tumors generated from cRb-/-/RasV12 cells showed a high degree of vascularization (Figure 2E) and necrotic regions surrounding the tumoral core, caused by the chaotic cell growth observed in the tumoral morphology resembling to those observed in human GBMs. However, the tumors observed in mice injected with cRbloxP/loxP/RasV12 astrocytes bore a strong similarity with human low-grade gliomas, showing moderate cellularity and few mitosis (Figure 2E). Therefore, although in other cell systems like MEFs, [17], [21], [33] it seems to be indispensable the loss of at least one tumor suppressor to make cells more susceptible to Ras-induced hyper-replication effects. In primary astrocytes, HRasV12 oncogenic activity alone is sufficient to unleash cellular hyper-proliferation but not in vivo tumor formation. Then, Rb inactivation, besides enhancing cellular growth in HRasV12-expressing astrocytes (Figures 1A, 1B and 1C), also confers a higher aggressiveness to the tumor (Figures 2C and 2D).
###end p 22
###begin p 23
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 260 263 260 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Irani1">[36]</xref>
###xml 703 706 703 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 806 810 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Woo1">[37]</xref>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Mitsushita1">[38]</xref>
###xml 1161 1163 1161 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1163 1172 1163 1172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1176 1179 1176 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1185 1187 1185 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1187 1190 1187 1190 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1194 1197 1194 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1246 1248 1246 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1250 1259 1250 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g003">Figure 3A</xref>
###xml 1315 1326 1315 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g003">Figure 3B&#8211;D</xref>
###xml 1361 1364 1361 1364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1437 1439 1437 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1439 1448 1439 1448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1452 1455 1452 1455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1461 1463 1461 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1463 1466 1463 1466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1470 1473 1470 1473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1570 1579 1570 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g003">Figure 3D</xref>
###xml 1584 1593 1584 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003632.s001">Figure S1</xref>
###xml 1651 1653 1651 1653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1653 1662 1653 1662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1666 1669 1666 1669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1675 1677 1675 1677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1677 1680 1677 1680 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1684 1687 1684 1687 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1711 1713 1711 1713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1713 1716 1713 1716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1742 1751 1742 1751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003632.s001">Figure S1</xref>
###xml 1978 1994 1978 1994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g003">Figure 3B and 3C</xref>
###xml 2347 2349 2347 2349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 2349 2358 2349 2358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 2362 2365 2362 2365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 2371 2373 2371 2373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 2373 2376 2373 2376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2380 2383 2380 2383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 909 914 <span type="species:ncbi:9606">human</span>
###xml 947 952 <span type="species:ncbi:9606">human</span>
As we previously described, although astrocytes harboring HRasV12 did not enter senescence we wanted to confirm whether DNA damage provoked by DNA replication stress, and usually associated with oncogene-induced senescence, was present. On the other hand, HRasV12 is also known to cause an increase in reactive oxygen species (ROS) production [36] as a result of replication stress. ROS has been traditionally considered as a toxic by-product of cellular metabolism, but it has been appreciated that they are actively involved in oncogenic signaling in cellular transformation and cancer. Increased intracellular levels of ROS have also been reported to mediate some biological effects of oncogenic HRasV12, such as the onset of premature senescence in primary cells, the generation of genomic instability [37], and malignant transformation [38]. Furthermore, high levels of ROS have been detected in several human cancer cell lines as well as in human tumors from different tissues. Taken together these reports, we wanted to analyze in astrocytes the relationship between oxidative stress and glioma. We observed similar oncogene-induced ROS accumulation in cRbloxP/loxP/RasV12 and cRb-/-/RasV12 astrocytes, but not in those that had lost only Rb (Figure 3A). Likewise, we found signs of chromosomal instability (Figure 3B-D) in the groups that expressed HRasV12 and displayed ROS accumulation. One of the most remarkable features of cRbloxP/loxP/RasV12 and cRb-/-/RasV12 astrocytes is the abundance of centromeric instability manifested as centromere fragments (CF) (Figure 3D and Figure S1). We also found Robertsonian centromere fusion (Rob) in cRbloxP/loxP/RasV12 and cRb-/-/RasV12 astrocytes but not in cRb-/- and wildtype astrocytes (Figure S1). In addition, there were numerical chromosome abnormalities in the experimental groups that expressed oncogenic Ras. These astrocytes presented >80 chromosomes per cell, doubling the chromosome number found in control cells (Figure 3B and 3C). Hence, these numerical and structural chromosome abnormalities show that activated Ras is sufficient to induce chromosomal instability in the absence of other signals, suggesting that Ras-induced chromosomal instability arises as consequence of ROS accumulation and DNA replication stress. In addition, there is not a significant difference between cRbloxP/loxP/RasV12 and cRb-/-/RasV12 astrocytes implying that the absence of pRb has not effect on DNA lesions, either quantitative or qualitative.
###end p 23
###begin title 24
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
HRasV12-dependent production of reactive oxygen species (ROS) and associated chromosomal instability.
###end title 24
###begin p 25
###xml 217 226 217 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 215 226 215 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>loxP/loxP</sup></italic>
###xml 230 233 230 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 241 244 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>&#8722;/&#8722;</sup></italic>
###xml 248 251 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 270 273 270 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 267 273 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cRb<sup>&#8722;/&#8722;</sup></italic>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 288 297 288 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 285 297 285 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cRb<sup>loxP/loxP</sup></italic>
###xml 301 304 301 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 350 352 350 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 352 361 352 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 367 369 367 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 369 372 369 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 415 417 415 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 417 426 417 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 429 431 429 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 431 440 431 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 444 447 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 450 452 450 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 452 455 452 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 461 463 461 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 463 466 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 799 801 799 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 801 810 801 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 815 818 815 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cRb</italic>
###xml 818 821 818 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 870 872 870 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 872 881 872 881 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 885 888 885 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 896 899 896 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 894 899 894 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb<sup>&#8722;/&#8722;</sup></italic>
###xml 903 906 903 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1017 1019 1017 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1019 1028 1019 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1032 1035 1032 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1041 1043 1041 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1043 1046 1043 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1050 1053 1050 1053 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1309 1311 1309 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1311 1320 1311 1320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1324 1327 1324 1327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
a, cells were assayed for dihydroethidium (DHE) fluorescence, indicative of ROS production and visualized by fluorescent microscopy. Under identical imaging conditions, DHE oxidation was significantly increased in cRbloxP/loxP/RasV12 and cRb-/-/RasV12 astrocytes. b, cRb-/-/RasV12 and cRbloxP/loxP/RasV12 cells are significantly more aneuploid than cRbloxP/loxP and cRb-/- cells. c, Absolute chromosome numbers of cRbloxP/loxP, cRbloxP/loxP/RasV12, cRb-/- and cRb-/-/RasV12 cells, showing the presence of diploid and tetraploid populations. Representative data of at least three independent experiments. d, Band G (Wright S) and telomere fluorescence in situ hybridization (T-Fish) was performed using a Cy3-labeled peptide nucleic acid (PNA) telomeric probe. Representative metaphase spreads from cRbloxP/loxP and cRb-/-, partial representative metaphase spreads from cRbloxP/loxP/RasV12 and cRb-/-/RasV12 stained with Wright and hybridized with Cy3 telomeric probe are shown. The regions of metaphase spreads from cRbloxP/loxP/RasV12 and cRb-/-/RasV12 are magnified in the lower panel to show centromere fragments (CF), acentric fragment (AF), chromatide type break (CTB), telomeric fusion (TF), robertsonian translocation (Rob) and other type of translocation (T). X indicates quadrivalent (Qua) found in cRbloxP/loxP/RasV12.
###end p 25
###begin p 26
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-DiMicco1">[21]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Collado1">[18]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Michaloglou1">[39]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Mallette1">[41]</xref>
###xml 474 479 474 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4A</sup>
###xml 487 490 487 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Collado1">[18]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Holland3">[31]</xref>
###xml 718 723 718 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4A</sup>
###xml 728 731 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 739 743 739 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 769 772 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 871 876 871 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ser15</sup>
###xml 922 925 918 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1013 1022 1009 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g004">Figure 4A</xref>
###xml 1113 1115 1109 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1115 1118 1111 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1122 1125 1118 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1143 1145 1139 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1145 1154 1141 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1158 1161 1154 1157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1179 1181 1175 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1181 1184 1177 1180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1188 1191 1184 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1235 1244 1231 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g004">Figure 4A</xref>
###xml 394 399 <span type="species:ncbi:9606">human</span>
These observations suggest that the presence of DNA lesions may trigger DDR activation. Although the mechanisms that generate DNA damage put in place by different oncogenic events are unclear presently, Ras activation induces not only ROS-induced DNA damage but also re-replication, an event known to cause DDR activation [21]. DDR is likely to be related to premalignant neoplastic lesions in human [18], [39]-[41], and has been linked to increased expression levels of p16INK4A and p19ARF[18], which appear mutated in a vast proportion of GBMs [31]. Consequently, and considering that these cells were proliferating, we expected these DDR checkpoints to appear down-regulated. Surprisingly, we observed a rise of p16INK4A, p19ARF and p21CIP1 expression levels in HRasV12-expressing astrocytes despite of the lack of senescence induction. Accordingly, detection of p-p53Ser15 and phosphorylated histone gamma-H2AX in HRasV12 expressing cells suggested DNA damage induced by the Ras-driven DNA hyper-replication (Figure 4A). Moreover, protein levels and their phosphorylation status were significantly higher in cRb-/-/RasV12 astrocytes than cRbloxP/loxP/RasV12 indicating that cRb-/-/RasV12 cells showed higher checkpoint activation (Figure 4A).
###end p 26
###begin title 27
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb loss</italic>
Rb loss enhances DNA damage response (DDR) induced by oncogenic Ras and reduces the p-p38MAPK levels by upregulation of Wip1.
###end title 27
###begin p 28
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 64 69 64 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 74 78 74 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1</sup>
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 102 107 102 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ser15</sup>
###xml 122 128 118 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ser139</sup>
###xml 130 132 126 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
a, HRasV12 is able to induce DDR markers expression, such as p16INK4a, p21Cip1 and p19ARF, p53 and p53ser15 and gamma-H2AXser139. Rb loss, in the presence of oncogenic Ras, increases this response. Immunoblot analysis was performed on astrocytes lysates prepared at day 6 after co-infection and selection with puromycin. b, Immunoblot analysis of p-p38MAPK and Wip1 levels was performed on cell lysates prepared at day 5 from co-infection and selection with puromycin. Densitometric analysis (in relative densitometric units) of Wip1 and p-p38MAPK protein levels. c, TMA analysis of Wip1 expression in glioma clinical samples. Representative pictures of samples are shown. The table shows median values. Wip1 immunoreactivity intensity was assigned according to the following scale: NA, non-assessable cases; -, less than 10% of neoplastic cells displayed immunoreactivity; +, 11-29% of neoplastic cells displayed immunoreactivity; ++, 30% or greater percentage of neoplastic cells displayed immunoreactivity. Phospho-histone H3 was used as a proliferation marker. Scale bars, 50 microm.
###end p 28
###begin p 29
###xml 50 52 50 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Bao1">[42]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Soutoglou1">[43]</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Toledo1">[44]</xref>
###xml 536 538 536 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 829 833 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Powers1">[29]</xref>
###xml 835 839 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Bosco1">[45]</xref>
###xml 936 938 936 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Peeper1">[33]</xref>
###xml 1002 1006 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Sage1">[46]</xref>
###xml 1061 1063 1061 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1136 1146 1136 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g004">Figures 4A</xref>
###xml 1151 1153 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003632.s002">S2</xref>
This difference can be explained by the fact that Rb inactivation is able to trigger this response in a DNA damage-independent manner. Recently, it has been shown that DNA damage-resistant glioma cells show preferential activation of DDR contributing to an increased survival of these cells [42]. This response may be initiated by the recruitment of repair factors to the site of DNA damage to form a multiprotein repair complex. The activation of this response does not require DNA lesions [43], [44], which may be readily repaired in Rb-deficient cells due to the elevated levels of repair factors activated in these responses. In fact, loss of pRb may deregulate cell cycle checkpoints, allowing the propagation of deleterious mutations, such as the ones produced by Ras-induced hyper-replication to promote tumor progression [29], [45]. Interestingly, several studies have reported the instrumental role of p107 in compensating the Rb loss, thus preventing the cell to undergo transformation [33], [46]. However, up-regulation of this pocket protein due to Rb inactivation apparently has a null effect on Ras-expressing astrocytes (Figures 4A and S2).
###end p 29
###begin p 30
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Reinhardt1">[47]</xref>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Wang1">[23]</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Dolado1">[25]</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Chen1">[48]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Sun1">[49]</xref>
###xml 583 587 583 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Dolado1">[25]</xref>
Also, p38MAPK has been reported to function downstream DNA damage sensors such as ATM and ATR after genotoxic insult [47]. Besides that, the p38MAPK pathway is known to become activated upon cellular stress, blocking proliferation or promoting apoptosis [23]-[25], [48], [49]. p38MAPK mediates multiple cellular processes but apparently its role in stress response is one of the key factors in Ras-induced senescence. Thus, p38MAPK acts as a sensor of oxidative stress during the initiation of tumorigenesis and regulates negatively malignant transformation induced by oncogenic Ras [25]. Given that, we wanted to know how p38MAPK is regulated in our model.
###end p 30
###begin p 31
###xml 121 123 121 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 123 132 123 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 200 209 200 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g004">Figure 4B</xref>
###xml 214 223 214 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003632.s003">Figure S3</xref>
###xml 291 293 291 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 392 401 392 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g003">Figure 3A</xref>
###xml 452 454 452 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 454 463 454 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 467 470 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 476 478 476 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 478 481 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 485 488 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
Therefore, we next investigated whether p38MAPK phosphorylation is raised in response to different oncogenic stimuli in cRbloxP/loxP astrocytes. Thus, we observed that Ras induced p38MAPK activation (Figure 4B and Figure S3). Curiously, when the expression of oncogenic Ras is combined with Rb deletion the levels of activated p38MAPK are depleted. In the view of ROS levels described above (Figure 3A), we expected similar p38MAPK activation both in cRbloxP/loxP/RasV12 and cRb-/-/RasV12 groups.
###end p 31
###begin p 32
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Fiscella1">[50]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Takekawa1">[51]</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Bulavin2">[52]</xref>
###xml 613 617 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Hershko1">[30]</xref>
###xml 660 662 660 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 787 796 787 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g004">Figure 4B</xref>
###xml 453 459 <span type="species:ncbi:10090">murine</span>
The first specific phosphatase of p38MAPK to be identified was Wip1 [50]. Wip1 is a serine/threonine phosphatase of the type 2C protein phosphatase family (PP2C). This family of phosphatases, highly conserved in eukaryotes, is frequently associated with regulation of cellular stress responses [51]. An important amount of data published in the last years suggests that Wip1 is an oncogene. This phosphatase cooperates with other oncogenes to transform murine embryonic fibroblasts [52]. Recently, it has been reported that E2F-1 down-regulates p38MAPK signaling pathway through E2F-induced up-regulation of Wip1 [30]. Accordingly, in our experimental setting Rb-null glial cells showed increased levels of this phosphatase, which explains the down-regulation of phosphorylated p38MAPK (Figure 4B).
###end p 32
###begin p 33
###xml 175 184 175 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g004">Figure 4C</xref>
###xml 38 43 <span type="species:ncbi:9606">human</span>
To further validate our observations, human low- and high-grade glioma sections were labeled for this marker. High levels of Wip1 expression correlate with high-grade tumors (Figure 4C).
###end p 33
###begin p 34
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Rayter1">[57]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Yoda1">[58]</xref>
###xml 356 358 356 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 365 368 365 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 376 385 376 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g005">Figure 5A</xref>
###xml 493 502 490 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g005">Figure 5B</xref>
###xml 551 553 548 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 553 562 550 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 566 569 563 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 575 577 572 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 577 580 574 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 584 587 581 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 668 677 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003632.s004">Figure S4</xref>
###xml 714 719 711 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppm1d</italic>
###xml 719 722 716 719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 796 800 793 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Bulavin2">[52]</xref>
Also, to test our hypothesis regarding the Ras-pRb loss cooperation mediated by Wip1 all experimental groups were treated with two chemical inhibitors upon infection, CCT007093 [57] and Arsenic Trioxide [58]. As a result, dephosphorylation of p38MAPK by Wip1 was blocked as demonstrated by the increased level of phosphorylated p38MAPK, especially in the cRb-/-/RasV12 group (Figure 5A). This biochemical outcome correlates with the positive staining observed in SA-beta-Galactosidase assays (Figure 5B). In addition, proliferation rates observed in cRbloxP/loxP/RasV12 and cRb-/-/RasV12 treated groups were significantly lower that the same cells without treatments (Figure S4), confirming previous reports where Ppm1d-/- MEFs showed reduced proliferation rate with features of early senescence [52].
###end p 34
###begin title 35
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
Wip1 inhibition enables senescence in cRb-/-/RasV12 astrocytes.
###end title 35
###begin p 36
a, All the experimental groups were treated with the Wip1 chemical inhibitors CCT007093 and Arsenic Trioxide (ATO). Levels of p-p38MAPK were assessed by Western blot analysis as a readout of Wip1 phosphatase activity inhibition. b, SA-beta-galactosidase assays in all groups (without treatment, ATO treatment, CCT007093 treatment). The y-axis represents the percentage of-positive cells (mean and s.d.).
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 191 199 191 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 204 211 204 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Serrano1">[17]</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Chen1">[48]</xref>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Bartkova1">[19]</xref>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Bartkova2">[22]</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Williams1">[53]</xref>
###xml 799 802 799 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 829 831 829 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 898 900 898 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Peeper2">[54]</xref>
Collectively, our results show that astrocytes expressing oncogenic Ras display a strong proliferation in the absence of senescence, facilitating their transformation into tumoral cells both in vitro and in vivo. This observation has not been established in other lineages, where OIS blocks tumor progression [17], [48]. In addition to that, the activation of DNA damage checkpoint response detected in these cells raises some questions about the kind of relationship that DDR holds with OIS. Although it has been reported that OIS is a consequence of the activation of DDR [19]-[22] we observed that in astrocytes DDR activation does not necessary lead to senescence. At the same time, the pRb requirement for Ras-mediated transformation [53] was not found in our model. Our data indicate that HRasV12 is able to cooperate with Rb loss in the tumor malignization. This cooperation between Ras and Rb loss opposes the conception that pRb is an essential mediator that links Ras-dependent mitogenic signaling to cell cycle regulation [54].
###end p 38
###begin p 39
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Dolado1">[25]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Bulavin3">[55]</xref>
###xml 243 245 243 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 335 337 335 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 350 353 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 417 419 417 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 500 502 500 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Hershko1">[30]</xref>
###xml 790 792 790 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 792 795 792 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 799 802 799 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 818 820 818 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 820 829 820 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 833 836 833 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 962 964 962 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 964 967 964 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 971 974 971 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 1293 1297 1293 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Yamaguchi1">[56]</xref>
###xml 1298 1302 1298 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003632-Yoda1">[58]</xref>
###xml 1430 1438 1430 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003632-g006">Figure 6</xref>
###xml 896 901 <span type="species:ncbi:9606">human</span>
Given that p38MAPK-deficient cells are sensitized to HRasV12-induced transformation [25] and although the inactivation of Wip1 is related to the inhibition of tumorigenesis [55], our data point out that the cooperation between Ras and loss of Rb could be due to the increase of Wip1 and consequently p38MAPK inactivation. In this way, Rb loss in HRasV12-expressing astrocytes confers a double advantage. On one hand, Rb absence increases the astrocytes proliferative rate but on the other hand, in a Rb knock-out context, E2F-1 is activated and up-regulates both DNA damage response in an DNA damage-independent manner, favoring repair mechanisms, and Wip1 [30], leading to an inactivation of p38MAPK and thus increasing cellular transformation. All of this may explain the low latency of cRb-/-/RasV12 tumors versus cRbloxP/loxP/RasV12 tumors and the high Wip1 expression observed in high-grade human gliomas. Interestingly enough, Wip1 chemical inhibition in cRb-/-/RasV12 astrocytes leads to a significant fall in the proliferative rate of these cells, which eventually enter senescence as opposed to cells where Wip1 remains unaffected. Lately, several authors have proposed the use of selective therapeutic inhibitors targeting Wip1 as a promising treatment for different types of cancer [56]-[58]. This study sheds new lights on the possible mechanisms behind the progression from preneoplastic lesions to malignant tumors (Figure 6), and according to our glioma model identifies Wip1 as a potential druggable target for new therapeutic approaches for a tumor whose bad prognosis has not significantly changed over the past two decades.
###end p 39
###begin title 40
###xml 20 22 20 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
DDR is modulated by Rb loss switching premalignant lesion to cancer.
###end title 40
###begin title 41
Materials and Methods
###end title 41
###begin title 42
Cell culture and SA beta-Galactosidase assay
###end title 42
###begin p 43
###xml 32 34 32 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 34 43 34 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 355 358 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 370 372 370 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 395 402 395 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Phoenix</italic>
###xml 487 490 487 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 241 247 <span type="species:ncbi:9913">bovine</span>
Astrocytes were generated from cRbloxP/loxP neonatal mice at day 3. The care and use of all experimental animals was in accordance with institutional guidelines. Cells were maintained in Dulbecco modified Eagle medium (Sigma) with 10% fetal bovine serum, 1% L-glutamine, and 1% penicillin/streptomycin (GIBCO-Invitrogen). For introduction of an activated Ras allele and Rb loss into astrocytes, Phoenix-Eco packaging cells (a gift from G.P. Nolan) were transfected with pBABE, pBABE-HRasV12, PIG-puro and PIG-CRE retroviral plasmids (a gift from P.P. Pandolfi). SA-beta-galactosidase activity was assessed with the Senescence beta-Galactosidase Staining Kit (Cell Signaling).
###end p 43
###begin title 44
Immunoblot
###end title 44
###begin p 45
###xml 638 640 634 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
Cultures were washed twice in ice-cold PBS, lysed in ice-cold RIPA buffer (1x PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mg/ml PMSF, 40 microg of aprotinin/ml, 100 mM orthovanadate). Analysis of protein levels was carried out by immunoblot analysis using polyclonal antibodies (Abs) against p53 (CM5; Novocastra), p-p53 ser15 (9284; Cell Signaling), p19ARF (ab80; Abcam), p38 (C-20; Santa Cruz), p-p38 (Thr180/Tyr182) (sc-17852; Santa Cruz), p16 (M-156; Santa Cruz), p107 (C-18; Santa Cruz), p-H2AX Ser139 (07-164 Upstate) and WIP-1 (H-300; Santa Cruz) and the monoclonal antibodies pan-Ras (Ab-3; Calbiochem), pan-Ras-V12 (Ab-1; Calbiochem), anti-alpha-Tubulin (T5168; Sigma) and Rb (554136; BD). Densitometric analyses were performed using UN-SCAN-IT software (Silk Scientific, UT, USA).
###end p 45
###begin title 46
Immunohistochemistry
###end title 46
###begin p 47
###xml 16 21 <span type="species:ncbi:9606">human</span>
Twenty cases of human astrocytomas, ten low-grade (grades I-II) and ten high-grade (grade III-IV), were retrieved from the files of the Pathology Department of the Clinical University Hospital, Santiago de Compostela, Spain. The tumors had been diagnosed according to standard criteria from the last WHO classification. Two tissue microarrays (TMAs) were constructed from these cases using a Tissue Arrayer device (Beecher Instruments, Sun Prairie, WI). Two selected 1.5-mm diameter cylinders from two representative areas histologically reviewed were included in each case. Internal and external appropriate controls were included in each TMA. TMA blocks were sectioned to produce 4-microm sections. Immunohistochemistry was performed using a universal second antibody kit that used a peroxidase-conjugated labeled-dextran polymer (Envision Plus, Dako, Denmark). The following primary antibodies were used: Wip1 (polyclonal, Santa Cruz Biotechnology, USA), phospho-histone H3 (polyclonal, Cell Signaling Technology) and p-p38 (polyclonal, Santa Cruz Biotechnology). Prior to immunostaining, antigen retrieval was performed by the sections in buffer by 20 min (Tris-EDTA pH 9 for Wip1 and p-p38, citrate buffer pH 6 for H3). Overnight incubation at 4degreesC was performed with every antibody.
###end p 47
###begin title 48
Metaphase chromosome preparation and FISH
###end title 48
###begin p 49
Metaphase spreads were prepared from exponentially growing cells after treatment with colcemid (0.1 microg/ml) for 7 hr. Cells were incubated in hypotonic buffer (0.05 M KCl, 0.0034 M trisodium citrate) for 20 min at 37degreesC and fixed 75% methanol, 25% acetic acid. Cells were then spotted onto microscope slides and stained with 2% Wright in Gurr buffer (pH 7.0). Metaphase chromosomes were scored using a Leica 2005 microscope under a 100x oil objective lens. At least 50 metaphases were analyzed from three independent experiments. TFISH was performed on unstained metaphase chromosomes using a Cy3- labeled peptide nucleic acid probe. For T-FISH, both the DNA probe and the slides were heat denatured (80degreesC for 5 min) and hybridized at 37degreesC for 2 hr accordance with the manufacturer's specifications (Dako Cytomation). Slides were counterstained with DAPI, and the images were captured using a Leica 2005 microscope equipped with the software program by Leica 4000.
###end p 49
###begin title 50
Wip1 inhibition treatment
###end title 50
###begin p 51
###xml 1 3 1 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb</italic>
###xml 3 12 3 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V12</sup>
cRbloxP/loxP conditional astrocytes were co-infected with PIG/pBABE, PIG/pBABE-HRasV12, PIG-Cre/pBABE and PIG-Cre/pBABE-HRasV12 retroviral vectors. Cells were plated in triplicate and treated either with CCT007093 (Maybridge, Cornwall, UK) or Arsenic Trioxide (Sigma) in the second day upon infection at a concentration of 25 microM and 10 microM, respectively. Subsequent cell fixation and crystal violet staining were carried out in the indicated days.
###end p 51
###begin title 52
Supporting Information
###end title 52
###begin p 53
###xml 178 183 <span type="species:ncbi:10090">mouse</span>
Telomere fluorescence in situ hybridization (T-FISH) of metaphase spreads. Merged images of DAPI (blue) and telomeric probe (red). The selected regions of metaphase spreads from mouse astrocytes infected with HRASV12 are magnified to show centromere fragments (CF) and Robertsonian centromeric fusion (Rob), indicated by arrows.
###end p 53
###begin p 54
(3.00 MB TIF)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin p 56
Acute deletion of Rb in astrocytes and analysis of pRb and p107 levels. Immunoblot analysis of proliferating cRbloxP/loxP astrocytes after infection at day 1 and 6 post-selection with puromycin. pRb was no longer detectable at day 1 after selection. The pRb family member p107 was significantly affected by loss of pRb. Compensation of pRb loss by p107 presence is already present at day 1.
###end p 56
###begin p 57
(3.00 MB TIF)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
Acute deletion of Rb in astrocytes and the effect on Wip1 and pp38 levels. Immunoblot analysis of proliferating cRb loxP/loxP astrocytes after infection at day 1 and 6 post-selection with puromycin. The lower level of pp38 is shown after 7 days but not at day 1 after selection.
###end p 59
###begin p 60
(3.00 MB TIF)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
Wip1 inhibition decreases the proliferation rate in cRb-/-/RasV12 astrocytes. All the experimental groups were treated with the Wip1 chemical inhibitors CCT007093 and Arsenic Trioxide (ATO). The relative cell number of early-passage cRbloxP/loxP conditional astrocytes co-infected with PIG/pBABE (vector), PIG/pBABE-HRasV12, PIG-Cre/pBABE and PIG-Cre/pBABE-HRasV12 retroviral vectors, is shown. After infection, cells were plated in triplicate and fixed on the indicated days for subsequent staining with crystal violet. Each time point represents the mean+/-s.d. of total cumulative cell number (without treatment, ATO treatment, CCT007093 treatment).
###end p 62
###begin p 63
(3.00 MB TIF)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
###xml 173 179 173 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Brn</sup>
###xml 170 179 170 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rb1<sup>tm2Brn</sup></italic>
###xml 72 77 <span type="species:ncbi:10090">Mouse</span>
###xml 88 93 <span type="species:ncbi:9606">Human</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
We thank the members of Molecular Oncology Lab for helpful discussions; Mouse Models of Human Cancers Consortium (MMHCC) Repository, a NCI-funded resource, for providing Rb1tm2Brn mice.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
The new WHO classification of brain tumours.
###end article-title 67
###begin article-title 68
###xml 17 22 <span type="species:ncbi:9606">human</span>
Proliferation of human malignant astrocytomas is dependent on ras activation.
###end article-title 68
###begin article-title 69
Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by ras.
###end article-title 69
###begin article-title 70
Oncogenic ras and akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes.
###end article-title 70
###begin article-title 71
mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
###end article-title 71
###begin article-title 72
###xml 110 115 <span type="species:ncbi:10090">mouse</span>
###xml 125 130 <span type="species:ncbi:9606">human</span>
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
###end article-title 72
###begin article-title 73
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Pathological and molecular progression of astrocytomas in a GFAP:12 V-ha-ras mouse astrocytoma model.
###end article-title 73
###begin article-title 74
###xml 33 38 <span type="species:ncbi:9606">Human</span>
A Genetically Tractable Model of Human Glioma Formation.
###end article-title 74
###begin article-title 75
Deletion of p16 and p15 genes in brain tumors.
###end article-title 75
###begin article-title 76
CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
###end article-title 76
###begin article-title 77
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.
###end article-title 77
###begin article-title 78
CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines.
###end article-title 78
###begin article-title 79
Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines.
###end article-title 79
###begin article-title 80
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.
###end article-title 80
###begin article-title 81
Simultaneous Alterations of Retinoblastoma and p53 Protein Expression in Astrocytic Tumors.
###end article-title 81
###begin article-title 82
###xml 16 21 <span type="species:ncbi:9606">human</span>
INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence.
###end article-title 82
###begin article-title 83
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
###end article-title 83
###begin article-title 84
Tumour biology: Senescence in premalignant tumours.
###end article-title 84
###begin article-title 85
###xml 64 69 <span type="species:ncbi:9606">human</span>
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
###end article-title 85
###begin article-title 86
###xml 67 72 <span type="species:ncbi:9606">human</span>
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.
###end article-title 86
###begin article-title 87
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
###end article-title 87
###begin article-title 88
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
###end article-title 88
###begin article-title 89
Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence.
###end article-title 89
###begin article-title 90
Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a.
###end article-title 90
###begin article-title 91
p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis.
###end article-title 91
###begin article-title 92
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes.
###end article-title 92
###begin article-title 93
###xml 150 154 <span type="species:ncbi:10090">mice</span>
A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice.
###end article-title 93
###begin article-title 94
Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
###end article-title 94
###begin article-title 95
E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
###end article-title 95
###begin article-title 96
E2F1 modulates p38 MAPK phosphorylation via transcriptional regulation of ASK1 and Wip1.
###end article-title 96
###begin article-title 97
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Gliomagenesis: Genetic alterations and mouse models.
###end article-title 97
###begin article-title 98
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of rb in the external granular layer cells of the cerebellum.
###end article-title 98
###begin article-title 99
Escape from premature senescence is not sufficient for oncogenic transformation by ras.
###end article-title 99
###begin article-title 100
The Retinoblastoma Protein Is Linked to the Activation of Ras.
###end article-title 100
###begin article-title 101
H-Ras mutation modulates the expression of major cell cycle regulatory proteins and disease prognosis in oral carcinoma.
###end article-title 101
###begin article-title 102
Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts.
###end article-title 102
###begin article-title 103
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
###end article-title 103
###begin article-title 104
The superoxide-generating oxidase Nox1 is functionally required for ras oncogene transformation.
###end article-title 104
###begin article-title 105
###xml 57 62 <span type="species:ncbi:9606">human</span>
BRAFE600-associated senescence-like cell cycle arrest of human naevi.
###end article-title 105
###begin article-title 106
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
###end article-title 106
###begin article-title 107
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.
###end article-title 107
###begin article-title 108
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
###end article-title 108
###begin article-title 109
Activation of the cellular DNA damage response in the absence of DNA lesions.
###end article-title 109
###begin article-title 110
ATR signaling can drive cells into senescence in the absence of DNA breaks.
###end article-title 110
###begin article-title 111
RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult.
###end article-title 111
###begin article-title 112
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry.
###end article-title 112
###begin article-title 113
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.
###end article-title 113
###begin article-title 114
The p38 pathway provides negative feedback for ras proliferative signaling.
###end article-title 114
###begin article-title 115
PRAK is essential for ras-induced senescence and tumor suppression.
###end article-title 115
###begin article-title 116
###xml 14 19 <span type="species:ncbi:9606">human</span>
Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner.
###end article-title 116
###begin article-title 117
p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation.
###end article-title 117
###begin article-title 118
###xml 26 31 <span type="species:ncbi:9606">human</span>
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity.
###end article-title 118
###begin article-title 119
The retinoblastoma protein is required for ras-induced oncogenic transformation.
###end article-title 119
###begin article-title 120
Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein.
###end article-title 120
###begin article-title 121
Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(arf) pathway.
###end article-title 121
###begin article-title 122
Development of a substrate-based cyclic phosphopeptide inhibitor of protein phosphatase 2Cdelta, Wip1.
###end article-title 122
###begin article-title 123
A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.
###end article-title 123
###begin article-title 124
Arsenic Trioxide Augments Chk2/p53-mediated Apoptosis by Inhibiting Oncogenic Wip1 Phosphatase.
###end article-title 124
###begin p 125
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 125
###begin p 126
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by Spanish Ministry of Education and Science (SAF2005-00306) and Xunta de Galicia grants (PGIDIT05PXIB20801PR); Grupos emerxentes 2007/064) (J.A.C.), and by Fundacion de Investigacion Medica Mutua Madrilena (J.A.C., P.I.). J.A.C. is an Investigator of Ramon y Cajal Programme (Spanish Ministry of Education and Science). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 126

